CN220166027U - Plant growth hormone raw medicine wastewater treatment system - Google Patents
Plant growth hormone raw medicine wastewater treatment system Download PDFInfo
- Publication number
- CN220166027U CN220166027U CN202321712596.9U CN202321712596U CN220166027U CN 220166027 U CN220166027 U CN 220166027U CN 202321712596 U CN202321712596 U CN 202321712596U CN 220166027 U CN220166027 U CN 220166027U
- Authority
- CN
- China
- Prior art keywords
- tank
- wastewater
- collecting
- concentration
- plant growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000008635 plant growth Effects 0.000 title claims abstract description 38
- 102000018997 Growth Hormone Human genes 0.000 title claims abstract description 37
- 108010051696 Growth Hormone Proteins 0.000 title claims abstract description 37
- 239000000122 growth hormone Substances 0.000 title claims abstract description 37
- 238000004065 wastewater treatment Methods 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 239000002351 wastewater Substances 0.000 claims abstract description 215
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 130
- 238000004062 sedimentation Methods 0.000 claims description 49
- 238000006115 defluorination reaction Methods 0.000 claims description 26
- 239000005558 Fluroxypyr Substances 0.000 claims description 21
- MEFQWPUMEMWTJP-UHFFFAOYSA-N fluroxypyr Chemical compound NC1=C(Cl)C(F)=NC(OCC(O)=O)=C1Cl MEFQWPUMEMWTJP-UHFFFAOYSA-N 0.000 claims description 21
- 238000010992 reflux Methods 0.000 claims description 18
- OORIKNJWZHTXDC-UHFFFAOYSA-N CCCC(CC)C(CC)(C(=O)OCC)N Chemical compound CCCC(CC)C(CC)(C(=O)OCC)N OORIKNJWZHTXDC-UHFFFAOYSA-N 0.000 claims description 16
- 230000001112 coagulating effect Effects 0.000 claims description 15
- 230000007246 mechanism Effects 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 14
- 239000010802 sludge Substances 0.000 claims description 14
- 238000012544 monitoring process Methods 0.000 claims description 12
- 229940002612 prodrug Drugs 0.000 claims description 8
- 239000000651 prodrug Substances 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 6
- 230000005611 electricity Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 230000015556 catabolic process Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 description 21
- 238000012546 transfer Methods 0.000 description 10
- 230000020477 pH reduction Effects 0.000 description 9
- 239000005556 hormone Substances 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 8
- 239000010865 sewage Substances 0.000 description 7
- 230000015271 coagulation Effects 0.000 description 6
- 238000005345 coagulation Methods 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003344 environmental pollutant Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 231100000719 pollutant Toxicity 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003375 plant hormone Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- PWVXXGRKLHYWKM-UHFFFAOYSA-N 5-[2-(benzenesulfonyl)ethyl]-3-[(1-methylpyrrolidin-2-yl)methyl]-1h-indole Chemical compound CN1CCCC1CC(C1=C2)=CNC1=CC=C2CCS(=O)(=O)C1=CC=CC=C1 PWVXXGRKLHYWKM-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000005979 Forchlorfenuron Substances 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 241000876443 Varanus salvator Species 0.000 description 1
- 230000006578 abscission Effects 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000003311 flocculating effect Effects 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- GPXLRLUVLMHHIK-UHFFFAOYSA-N forchlorfenuron Chemical compound C1=NC(Cl)=CC(NC(=O)NC=2C=CC=CC=2)=C1 GPXLRLUVLMHHIK-UHFFFAOYSA-N 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- 231100001240 inorganic pollutant Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Abstract
The utility model relates to a plant growth hormone raw medicine wastewater treatment system, which relates to the technical field of plant growth hormone raw medicine production wastewater treatment. The low-concentration wastewater directly enters the collecting tank to be collected, the high-concentration wastewater is collected and pretreated through the first treatment assembly, so that the biotoxicity of the high-concentration wastewater is reduced, the high-salt wastewater is collected and pretreated through the second treatment assembly, the salt content in the wastewater is reduced, and the low-concentration wastewater, the high-concentration wastewater and the high-salt wastewater are collected and treated in a grading manner, so that the probability of system breakdown caused by direct collection of all the wastewater into the biochemical tank is reduced, and the efficiency of the plant growth hormone original wastewater treatment is improved.
Description
Technical Field
The utility model relates to the technical field of plant growth hormone technical production wastewater treatment, in particular to a plant growth hormone technical wastewater treatment system.
Background
Plant hormone refers to trace organic substances naturally occurring in plants and having remarkable effects on plant growth and development, and is also called as plant natural hormone or plant endogenous hormone. Its existence can influence and effectively regulate the growth and development of plant, including the whole process from cell growth, division to rooting, germination, flowering, fruiting, maturity and abscission, etc.
In agricultural production, in order to regulate the development process of crops, to achieve the purposes of stable yield and increase in yield, improvement of quality and enhancement of stress resistance of crops, usually, plant growth hormone is additionally used, and the plant growth hormone is also called a plant growth regulator, and is artificially synthesized chemical substances with regulation effect on growth and development of plants and natural plant hormone extracted from organisms. Common plant growth hormone pro-drugs include diethyl aminoethyl hexanoate, forchlorfenuron, gibberellin, indoleacetic acid, chlormequat chloride, fluroxypyr and the like.
The production process of the plant growth hormone raw medicine can produce a large amount of wastewater, including wastewater produced on a production line, equipment cleaning wastewater, circulating system sewage, domestic sewage and the like, the wastewater on the production line is divided into high-salt wastewater and high-concentration wastewater, the salt content in the high-salt wastewater is higher, the COD content in the high-concentration wastewater is higher, and the high-salt wastewater contains characteristic pollutants such as dimethylbenzene, trichloroethane and the like, a biological method is generally adopted for wastewater treatment in a factory, larger impurities in the wastewater are firstly removed, the wastewater is introduced into a biochemical pond, organic and inorganic pollutants in the wastewater are degraded by utilizing microorganisms through an A/O technology, for example, COD, ammonia nitrogen and total nitrogen are degraded by utilizing compound bacteria, ammonia nitrogen degradation rate is improved by utilizing anaerobic bacteria, and total nitrogen degradation is also carried out.
However, the source of the waste water of the raw plant growth hormone medicine is complex, the discharge period is not fixed, for example, the waste water generated by the diethyl aminoethyl hexanoate production line contains a large amount of dimethylbenzene, the waste water generated by the fluroxypyr production line contains a large amount of fluoride, part of the waste water has higher salt content, and all the waste water is directly introduced into a biochemical pond to cause the collapse of a biochemical system, so that the effect of waste water treatment is reduced, maintenance personnel are required to maintain, and the efficiency of the waste water treatment of the raw plant growth hormone medicine is reduced.
Disclosure of Invention
In order to improve the efficiency of the treatment of the plant growth hormone raw medicine wastewater, the utility model provides a plant growth hormone raw medicine wastewater treatment system.
The utility model provides a plant growth hormone original drug wastewater treatment system, which adopts the following technical scheme:
the utility model provides a plant growth hormone former medicine effluent disposal system, includes the mounting bracket, be provided with biochemical pond and clean water pond on the mounting bracket, clean water pond and biochemical pond intercommunication just are used for collecting the clear water after the processing, be provided with the treatment facility that is used for handling waste water on the mounting bracket, treatment facility includes:
the collecting tank is arranged on the mounting frame and connected with the biochemical tank, and the collecting tank is used for collecting low-concentration wastewater;
the first treatment assembly is arranged on the mounting frame and is used for collecting and pre-treating the high-concentration wastewater;
and the second treatment assembly is arranged on the mounting frame and is used for collecting and pre-treating the high-salt wastewater.
Through adopting above-mentioned technical scheme, equipment washs low concentration waste water such as sewage, circulation system blowdown water and domestic sewage directly gets into the collecting vat and collects, high concentration waste water that produces on the production line is collected and preliminary treatment through first processing subassembly, thereby reduce high concentration waste water's biotoxicity, high salt waste water is collected and preliminary treatment through second processing subassembly, thereby reduce the salt content in the waste water, through collecting and handling low concentration waste water, high concentration waste water and high salt waste water in grades, finally, the biochemical treatment is carried out in the pool of converging, the water after the treatment is converged into the clean water pool and is carried out subsequent utilization, thereby reduce the probability that all waste water directly converged into the biochemical pool causes the system to crash, consequently, the efficiency of plant growth hormone former medicine waste water treatment has been improved.
Optionally, the first processing component includes:
the high-concentration wastewater tank is arranged on the mounting frame and used for collecting high-concentration wastewater;
the first Fenton reactor is arranged on the mounting frame and is connected with the high-concentration wastewater pool;
the first coagulating sedimentation tank is arranged on the mounting frame and connected with the first Fenton reactor, and the first coagulating sedimentation tank is connected with the biochemical tank;
the high-concentration wastewater pool is provided with a first collecting assembly for collecting the diethyl aminoethyl hexanoate wastewater.
By adopting the technical scheme, the high-concentration wastewater is collected in the high-concentration wastewater pool, the wastewater in the high-concentration wastewater pool enters the first Fenton reactor for oxidation reaction, the purposes of ring opening and chain breakage and biotoxicity reduction are achieved, the oxidized high-concentration wastewater enters the first coagulating sedimentation pool, pollutants in the wastewater are coagulated to form floccules by adding medicaments, workers remove suspended matters, and the pretreated high-concentration wastewater finally enters the biochemical pool for biochemical treatment, so that the collection and pretreatment of the high-concentration wastewater are realized, the probability of system breakdown of the biochemical pool caused by the high-concentration wastewater is reduced, and the efficiency of plant growth hormone original wastewater treatment is improved; the xylene content in the diethyl aminoethyl hexanoate wastewater is higher, and the first collecting assembly starts to collect the diethyl aminoethyl hexanoate wastewater independently, so that the probability of reducing the pretreatment effect caused by the too high concentration of the diethyl aminoethyl hexanoate wastewater entering the pretreatment is reduced by controlling the content of the diethyl aminoethyl hexanoate wastewater entering the high concentration wastewater tank, and the efficiency of treating the stock plant growth hormone wastewater is improved.
Optionally, the first collecting assembly includes:
the first collecting tank is arranged on the mounting frame and used for collecting the diethyl aminoethyl hexanoate wastewater;
the first delivery pump is arranged on the first collecting tank and is communicated with the inside of the first collecting tank, and the first delivery pump is communicated with the high-concentration wastewater pool through a first delivery pipe.
Through adopting above-mentioned technical scheme, first collecting vessel carries out the individual collection to the bright ester waste water of amine, first delivery pump starts, the bright ester waste water of amine gets into high-concentration waste water pond through first conveyer pipe to with other waste water in the high-concentration waste water pond together is gathered in first Fenton's reactor and is carried out oxidation and subsequent treatment, through the pump volume of pumping of the bright ester waste water of control amine of first delivery pump control, thereby reduce the bright ester waste water concentration of amine that gets into the preliminary treatment and too high probability that leads to the preliminary treatment effect to reduce, with this efficiency that improves the former medicine waste water treatment of vegetation hormone.
Optionally, the second processing component includes:
the high-salt wastewater pond is arranged on the mounting frame and is used for collecting high-salt wastewater;
the defluorination sedimentation tank is arranged on the mounting frame, is connected with the high-salt wastewater tank and is used for defluorination of wastewater;
the three-effect evaporator is arranged on the mounting frame, is connected with the defluorination sedimentation tank and is used for removing salt in the wastewater, and the water outlet end of the three-effect evaporator is connected with the biochemical tank;
and a second collecting assembly for collecting the fluroxypyr is arranged on the high-salt wastewater tank.
By adopting the technical scheme, the high-salt wastewater is collected in the high-salt wastewater pool, the high-salt wastewater enters the defluorination sedimentation pool, the defluorination sedimentation pool is added with the medicament to defluorinate the high-salt wastewater, the defluorinated wastewater enters the triple-effect evaporator to remove salt, and the wastewater after removing the salt is infused into the biochemical pool to be subjected to biochemical treatment, so that the collection of the high-salt wastewater and pretreatment such as defluorination and desalination are realized, the probability of the high-salt wastewater causing the breakdown of a biochemical pool system is reduced, and the efficiency of the treatment of the plant growth hormone original drug wastewater is improved; fluoride content in the fluroxypyr waste water is higher, and the fluroxypyr waste water is singly collected through the second collecting component, so that the content of the fluroxypyr waste water entering a high-salt waste water tank is controlled, the probability of reducing the pretreatment effect caused by the too high concentration of the fluroxypyr waste water entering pretreatment is reduced, and the efficiency of treating the raw plant growth hormone waste water is improved.
Optionally, the second collecting assembly includes:
the second collecting tank is arranged on the mounting frame and is used for collecting the fluroxypyr wastewater;
the second delivery pump is arranged on the second collecting tank and is communicated with the second collecting tank, and the second delivery pump is communicated with the high-salt wastewater tank through a second delivery pipe.
Through adopting above-mentioned technical scheme, the second collecting tank carries out the individual collection to fluroxypyr waste water, the second delivery pump starts, fluroxypyr waste water gets into high salt waste water pond through the second conveyer pipe, and together with other waste water in the high salt waste water pond in the collection go on defluorination and follow-up desalination in the sedimentation tank, control fluroxypyr waste water's pump volume of feeding through control second delivery pump, thereby reduce the too high probability that leads to the preliminary treatment effect to reduce of fluroxypyr waste water concentration that gets into the preliminary treatment, with this efficiency that improves the former medicine waste water treatment of vegetation hormone.
Optionally, be provided with monitoring mechanism on the clean water basin, monitoring mechanism includes:
the water quality monitor is arranged on the clean water tank and is used for monitoring the water quality in the clean water tank;
the water outlet pipe is arranged on the clean water tank, is communicated with the clean water tank and is used for discharging the treated clean water, and is provided with a water outlet valve for controlling opening and closing, and the water outlet valve is electrically connected with the water quality monitor;
and the reflux assembly is arranged on the clean water tank and is connected with the biochemical tank.
Through adopting above-mentioned technical scheme, in the clean water tank was discharged to the water after the processing, the quality of water in the clean water tank was monitored to the quality of water monitor, after the quality of water reached emission standard, the outlet valve was started and was carried out the discharge of rivers, when the quality of water did not reach standard, the outlet valve was closed, the backward flow subassembly was started for the water in the clean water tank flows back to the biochemical pond and carries out the reprocessing, with this quality control who realizes the clean water tank discharge water, thereby the probability that the direct discharge of waste water that has not reached standard led to the fact the pollution to the environment has been reduced, consequently, the efficiency of the former medicine waste water treatment of vegetation hormone has been improved.
Optionally, the reflow assembly includes:
the reflux pump is arranged on the clean water tank and communicated with the interior of the clean water tank, and is electrically connected with the on-line monitor;
and the reflux pipe is arranged on the reflux pump and is communicated with the biochemical tank.
Through adopting above-mentioned technical scheme, when quality of water is up to standard, the outlet valve is closed, and the backwash pump starts, and the water in the clean water tank flows back to the biochemical pond through the backwash pipe and carries out biochemical treatment once more, until the quality of water in the clean water tank reaches standard, and the backwash pump is closed, and the outlet valve is opened to this has reduced the direct discharge of waste water that is up to standard and has led to the fact the probability of pollution to the environment, has consequently improved the efficiency of the former medicine waste water treatment of vegetation hormone.
Optionally, sludge pumps for discharging sludge are arranged on the biochemical tank, the clean water tank, the first coagulating sedimentation tank and the defluorination sedimentation tank.
Through adopting above-mentioned technical scheme, the sludge pump starts and pumps the sediment that produces among biochemical pond, clean water basin, first coagulating sedimentation tank and defluorination sedimentation tank to reduce the sediment and cause the probability of adverse effect to waste water treatment efficiency more, consequently improved the efficiency of the former medicine waste water treatment of vegetation hormone.
In summary, the present utility model includes at least one of the following beneficial technical effects:
the device washes sewage, circulation system arranges low concentration waste water such as sewage and domestic sewage and directly gets into the collecting vat and collects, the high concentration waste water that produces on the production line is collected and preliminary treatment through first treatment subassembly to this biotoxicity that reduces high concentration waste water, high salt waste water is collected and preliminary treatment through second treatment subassembly, with this salt content that reduces in the waste water, through collecting and handling low concentration waste water, high concentration waste water and high salt waste water in grades, finally, the biochemical treatment is carried out in the pool of converging, the water after the treatment is converged and is carried out follow-up utilization in the clean water pool, thereby reduce the probability that all waste water directly converged and cause the system crash in the biochemical pool, consequently, the efficiency of vegetation hormone former medicine waste water treatment has been improved.
Drawings
FIG. 1 is a schematic view of the overall structure of the present utility model;
FIG. 2 is a schematic diagram of the structure of a biochemical tank according to the present utility model;
FIG. 3 is a schematic view of a first processing assembly of the present utility model;
FIG. 4 is a schematic view of a second collection assembly of the present utility model;
FIG. 5 is a schematic view of a second processing assembly of the present utility model;
fig. 6 is a schematic diagram of the structure of the monitoring mechanism in the present utility model.
Reference numerals: 1. a mounting frame; 11. a biochemical pool; 111. a hydrolytic acidification zone; 112. an anaerobic zone; 113. an aerobic zone; 114. a precipitation zone; 12. a clean water tank; 13. a sludge pump; 2. a processing mechanism; 21. a collecting tank; 211. a low-concentration water inlet pipe; 212. a high-concentration water inlet pipe; 213. a high salt water inlet pipe; 22. a first processing assembly; 221. a high-concentration wastewater tank; 222. a first Fenton reactor; 223. a first coagulating sedimentation tank; 224. a circulation pipe; 225. a mud pipe; 23. a second processing assembly; 24. a high salt wastewater tank; 25. a defluorination sedimentation tank; 26. a triple effect evaporator; 261. a preheater; 262. a triple effect evaporation device; 263. a centrifuge; 264. a liquid discharge pipe; 3. a first collection assembly; 31. a first collection tank; 32. a first transfer pump; 321. a first delivery tube; 4. a second collection assembly; 41. a second collection tank; 42. a second transfer pump; 421. a second delivery tube; 5. a monitoring mechanism; 51. a water quality monitor; 511. a control module; 52. a water outlet pipe; 521. a water outlet valve; 53. a reflow assembly; 531. a reflux pump; 532. and (5) a return pipe.
Detailed Description
The utility model is described in further detail below with reference to fig. 1-6.
The embodiment of the utility model discloses a plant growth hormone original drug wastewater treatment system.
Referring to fig. 1 and 2, a plant growth hormone raw medicine wastewater treatment system comprises a mounting frame 1, wherein a biochemical tank 11 and a clean water tank 12 are fixedly arranged on the mounting frame 1, the biochemical tank 11 comprises a hydrolysis acidification zone 111, an anaerobic zone 112, an aerobic zone 113 and a sedimentation zone 114, the hydrolysis acidification zone 111, the anaerobic zone 112, the aerobic zone 113 and the sedimentation zone 114 are common technical means in the prior art, the explanation is not omitted in the embodiment of the utility model, the clean water tank 12 and the sedimentation zone 114 are communicated through a pump (not shown in the figure) and are used for collecting the treated clean water, and a treatment mechanism 2 for treating the wastewater is arranged on the mounting frame 1.
Referring to fig. 1 and 2, the treatment mechanism 2 comprises a collecting tank 21 and a first treatment assembly 22, wherein the collecting tank 21 is fixedly arranged on the upper surface of the mounting frame 1 and is used for collecting low-concentration wastewater, the collecting tank 21 is communicated with the hydrolytic acidification area 111 through a pump (not shown), a low-concentration water inlet pipe 211 is fixedly arranged on the outer side wall of the collecting tank 21, and the low-concentration water inlet pipe 211 is communicated with the inside of the collecting tank 21 and is used for conveying the low-concentration wastewater.
Referring to fig. 1 and 3, the first treatment assembly 22 is disposed on the mounting frame 1 and is used for collecting and pre-treating high-concentration wastewater, the first treatment assembly 22 comprises a high-concentration wastewater tank 221, the high-concentration wastewater tank 221 is fixedly mounted on the upper surface of the mounting frame 1 and is used for collecting high-concentration wastewater, a high-concentration water inlet pipe 212 is fixedly mounted on the outer side wall of the high-concentration wastewater tank 221, the high-concentration water inlet pipe 212 is communicated with the high-concentration wastewater tank 221 and is used for collecting high-concentration wastewater, and a first collection assembly 3 for collecting diethyl amine wastewater is disposed on the high-concentration wastewater tank 221.
Referring to fig. 1 and 3, the first collecting assembly 3 includes a first collecting tank 31 and a first transfer pump 32, the first collecting tank 31 is fixedly installed on the upper surface of the mounting frame 1 and is used for collecting the diethyl aminoethyl hexanoate wastewater, the water inlet end of the first transfer pump 32 is fixedly installed on the outer sidewall of the first collecting tank 31 and is communicated with the inside of the first collecting tank 31, and the water outlet end of the first transfer pump 32 is communicated with the high-concentration wastewater tank 221 through a first transfer pipe 321.
Referring to fig. 1 and 3, the first treatment assembly 22 further includes a first Fenton reactor 222 and a first coagulation sedimentation tank 223, the first Fenton reactor 222 is fixedly installed on the upper surface of the mounting frame 1, and a plurality of first Fenton reactors 222 can be arranged according to the requirement for series connection in actual production, and only one embodiment of the present utility model is illustrated as an example. The water inlet end of the first Fenton reactor 222 is connected with the high-concentration wastewater tank 221 through a pump (not shown in the figure), the first Fenton reactor 222 is used for oxidizing the high-concentration wastewater, and a circulating pipeline 224 for circulating the circulating water is fixedly arranged on the first Fenton reactor 222.
Referring to fig. 1 and 3, a first coagulating sedimentation tank 223 is fixedly installed on the upper surface of the mounting frame 1, the first coagulating sedimentation tank 223 adopts a pipe chute sedimentation method, the water inlet end of the first coagulating sedimentation tank 223 is connected with the water outlet end of the first Fenton reactor 222, the water outlet end of the first coagulating sedimentation tank 223 is communicated with the hydrolysis acidification region 111 through a pump, a sludge discharge pipe 225 is fixedly installed at the bottom end of the first coagulating sedimentation tank 223, and the sludge discharge pipe 225 is communicated with the first coagulating sedimentation tank 223 and is used for collecting sediment.
Referring to fig. 1 and 3, the high-concentration wastewater is collected in a high-concentration wastewater tank 221, the diethyl aminoethyl hexanoate wastewater independently enters a first collecting tank 31 for collection, a first conveying pump 32 is started to convey part of diethyl aminoethyl hexanoate wastewater into the high-concentration wastewater tank 221, and the wastewater in the high-concentration wastewater tank 221 enters a first Fenton reactor 222 for oxidation reaction, so that the purposes of ring opening, chain breakage and biotoxicity reduction are achieved.
Referring to fig. 1 and 3, the oxidized high-concentration wastewater enters a first coagulation sedimentation tank 223, a flocculating reaction is generated by adding a medicament such as PAC, PAM and the like to cause pollutants in the wastewater to form floccule precipitate, and the pretreated high-concentration wastewater finally enters a hydrolysis acidification area 111 for subsequent treatment, so that the collection and pretreatment of the high-concentration wastewater are realized, the probability of system collapse of a biochemical tank 11 caused by the high-concentration wastewater is reduced, and meanwhile, the pumping amount of the diethyl aminoethyl hexanoate wastewater is controlled by controlling a first conveying pump 32, so that the probability of reduction of pretreatment effect caused by overhigh concentration of the diethyl aminoethyl hexanoate wastewater entering the pretreatment is reduced, and the efficiency of the treatment of the plant growth hormone original wastewater is improved.
Referring to fig. 1 and 4, the treatment mechanism 2 further includes a second treatment assembly 23, the second treatment assembly 23 is disposed on the mounting frame 1 and is used for collecting and pretreating high-salt wastewater, the second treatment assembly 23 includes a high-salt wastewater tank 24, the high-salt wastewater tank 24 is fixedly mounted on the upper surface of the mounting frame 1 and is used for collecting high-salt wastewater, a high-salt water inlet pipe 213 is fixedly mounted on the outer side wall of the high-salt wastewater tank 24, the high-salt water inlet pipe 213 is communicated with the high-salt wastewater tank 24 and is used for collecting high-salt wastewater, and a second collecting assembly 4 for collecting fluroxypyr wastewater is disposed on the high-salt wastewater tank 24.
Referring to fig. 1 and 4, the second collecting assembly 4 includes a second collecting tank 41 and a second transfer pump 42, the second collecting tank 41 is fixedly installed on the upper surface of the mounting frame 1 and is used for collecting the fluroxypyr wastewater, the water inlet end of the second transfer pump 42 is fixedly installed on the outer side wall of the second collecting tank 41 and is communicated with the interior of the second collecting tank 41, and the water outlet end of the second transfer pump 42 is communicated with the high-salt wastewater tank 24 through a second transfer pipe 421.
Referring to fig. 4 and 5, the second treatment assembly 23 further includes a defluorination sedimentation tank 25 and a triple effect evaporator 26, the defluorination sedimentation tank 25 is identical to the first coagulation sedimentation tank 223 in structure, and adopts a inclined tube sedimentation method, the defluorination sedimentation tank 25 is used for defluorination of high-salt wastewater by adding a medicament, and a water inlet end of the defluorination sedimentation tank 25 is communicated with the high-salt wastewater tank 24 by pump delivery (not shown in the figure); the triple effect evaporator 26 is of a common triple effect evaporator structure in the prior art, the triple effect evaporator 26 comprises a preheater 261, a triple effect evaporation device 262, a centrifugal machine 263 and a condensate water recovery device (not shown in the figure), the water outlet end of the defluorination sedimentation tank 25 is connected with the preheater 261 through pump conveying, the preheater 261 is connected with the triple effect evaporation device 262 through pump conveying, the triple effect evaporator 26 is used for removing salt in high-salt wastewater, the water outlet end of the triple effect evaporation device 262 is connected with the centrifugal machine 263, a salt crystal outlet is formed in the bottom end of the centrifugal machine 263, a liquid discharge pipe 264 is fixedly arranged on the outer side wall of the centrifugal machine 263, and the liquid discharge pipe 264 is communicated with the hydrolytic acidification zone 111.
Referring to fig. 4 and 5, the high-salt wastewater tank 24 collects high-salt wastewater, the fluroxypyr wastewater singly enters the second collecting tank 41 to be collected, the second conveying pump 42 is started, part of fluroxypyr wastewater enters the high-salt wastewater tank 24 through the second conveying pipe 421, the wastewater in the high-salt wastewater tank 24 enters the defluorination sedimentation tank 25, and medicaments such as CaCl2, PAC, PAM and the like are added into the defluorination sedimentation tank 25, so that pollutants in water react to generate floccules, and the fluorides are removed.
Referring to fig. 4 and 5, the wastewater after defluorination enters a preheater 261 under the pressure of pump delivery, the preheated high-salt wastewater is concentrated and desalted by a triple-effect evaporation device 262, and finally enters a centrifugal machine 263, the centrifugal machine 263 is started, salt crystals are discharged and collected from a salt crystal discharge port, and the wastewater enters a hydrolysis acidification zone 111 through a liquid discharge pipe 264 for subsequent treatment, so that the collection of the high-salt wastewater and pretreatment such as defluorination and desalting are realized, the probability of system breakdown of a biochemical pond 11 caused by the high-salt wastewater is reduced, and the efficiency of plant growth hormone original drug wastewater treatment is improved; meanwhile, the second conveying pump 42 is controlled to control the inflow amount of the fluroxypyr wastewater, so that the probability of reducing the pretreatment effect caused by the fact that the concentration of the fluroxypyr wastewater entering pretreatment is too high is reduced, and the efficiency of treating the plant growth hormone original drug wastewater is improved.
Referring to fig. 1 and 2, the pretreated high-concentration wastewater, high-salt wastewater and low-concentration wastewater are all collected into a hydrolysis acidification area 111, and the facultative anaerobe is utilized to hydrolyze the selected mailing solids and the difficult-to-biodegrade macromolecular substances into soluble organic substances and easy-to-biodegrade micromolecular substances in the wastewater, the micromolecular organic substances are converted into volatile fatty acids under the action of the acidifier, the hydrolyzed and acidified wastewater sequentially passes through an anaerobic area 112 and an aerobic area 113 to remove COD and denitrogenation, and finally the wastewater enters a sedimentation area 114 to be precipitated, and the muddy water mixture of the aerobic area 113 is separated, so that the SS entering a clean water tank 12 is reduced.
Referring to fig. 1 and 4, the biochemical tank 11, the clean water tank 12, the first coagulation sedimentation tank 223 and the defluorination sedimentation tank 25 are provided with sludge pumps 13 for discharging sludge, the sludge pumps 13 on the first coagulation sedimentation tank 223 and the defluorination sedimentation tank 25 are connected with a sludge discharge pipe 225, and an outlet end of the sludge pumps 13 is used for being connected with sludge treatment equipment, which is not described in the present utility model.
Referring to fig. 1 and 6, a monitoring mechanism 5 is arranged on the clean water tank 12, the monitoring mechanism 5 comprises a water quality monitor 51, a water outlet pipe 52 and a backflow component 53, the water quality monitor 51 is fixedly arranged on the upper surface of the mounting frame 1, the monitoring end of the water quality monitor 51 extends into the clean water tank 12 and is used for carrying out on-line monitoring on the water quality in the clean water tank 12, and a control module 511 is fixedly arranged on the water quality monitor 51; the water outlet pipe 52 is fixedly arranged on the outer side wall of the clean water tank 12, the water outlet pipe 52 is communicated with the clean water tank 12 and used for discharging the treated clean water, a water outlet valve 521 which is controlled to be opened and closed is arranged on the water outlet pipe 52, the water outlet valve 521 is an electromagnetic valve, and the water outlet valve 521 is electrically connected with the control module 511.
Referring to fig. 1 and 6, a reflux assembly 53 is disposed on the clean water tank 12 and connected with the biochemical tank 11, the reflux assembly 53 includes a reflux pump 531 and a reflux pipe 532, a water inlet end of the reflux pump 531 is fixedly mounted on an outer side wall of the clean water tank 12 and is communicated with the interior of the clean water tank 12, and the reflux pump 531 is electrically connected with the control module 511; the return pipe 532 is fixedly arranged on the water outlet end of the return pump 531, and the end of the return pipe 532 away from the return pump 531 is communicated with the aerobic zone 113.
Referring to fig. 1 and 6, the precipitated clean water enters the clean water tank 12, the water quality monitor 51 monitors the water quality on line, when the water quality reaches the standard, the control module 511 controls the water outlet valve 521 to be opened, meanwhile, the reflux pump 531 is closed, water flow is discharged from the water outlet pipe 52, when the pollutant in the water quality exceeds the standard, the water outlet valve 521 is closed, the reflux pump 531 is opened, and the water flow is refluxed to the aerobic zone 113 for further treatment under the action of the reflux pump 531, so that the effect of the treatment of the plant growth hormone raw medicine wastewater is improved.
The working principle of the embodiment of the utility model is as follows:
the high-concentration wastewater is collected through the high-concentration wastewater tank 221, simultaneously, the diethyl aminoethyl hexanoate wastewater is collected independently, and the high-concentration wastewater is oxidized, opened and broken in a chain through the first Fenton reactor 222 and the first coagulation sedimentation tank 223, so that the biotoxicity of the high-concentration wastewater is reduced; the high-salt wastewater is collected through a high-salt wastewater tank 24, and the fluroxypyr is collected independently, and defluorinated and desalted through a defluorinated sedimentation tank 25 and a three-effect evaporator 26 in combination; the pretreated high-salt wastewater, high-concentration wastewater and low-concentration wastewater are gathered into the biochemical tank 11 for biochemical treatment and finally discharged through the clean water tank 12, and the low-concentration wastewater, the high-concentration wastewater and the high-salt wastewater are collected and treated in a grading manner, so that the probability of system breakdown caused by the direct gathering of all the wastewater into the biochemical tank 11 is reduced, and the efficiency of the treatment of the plant growth hormone raw material wastewater is improved.
The above embodiments are not intended to limit the scope of the present utility model, so: all equivalent changes in structure, shape and principle of the utility model should be covered in the scope of protection of the utility model.
Claims (8)
1. The utility model provides a plant growth hormone former medicine effluent disposal system, includes mounting bracket (1), be provided with biochemical pond (11) and clean water pond (12) on mounting bracket (1), clean water pond (12) and biochemical pond (11) intercommunication and be used for collecting the clear water after the processing, its characterized in that: be provided with on mounting bracket (1) and be used for carrying out treatment mechanism (2) to waste water, treatment mechanism (2) include:
the collecting tank (21) is arranged on the mounting frame (1) and is connected with the biochemical tank (11), and the collecting tank (21) is used for collecting low-concentration wastewater;
a first treatment assembly (22), the first treatment assembly (22) being arranged on the mounting frame (1) and being used for collecting and pre-treating high-concentration wastewater;
and the second treatment assembly (23) is arranged on the mounting frame (1) and is used for collecting and pre-treating the high-salt wastewater.
2. The plant growth hormone pro-drug wastewater treatment system of claim 1, wherein: the first processing assembly (22) comprises:
a high-concentration wastewater tank (221), wherein the high-concentration wastewater tank (221) is arranged on the mounting frame (1) and is used for collecting high-concentration wastewater;
a first Fenton reactor (222), wherein the first Fenton reactor (222) is arranged on a mounting frame (1) and is connected with a high-concentration wastewater tank (221);
the first coagulating sedimentation tank (223) is arranged on the mounting frame (1) and is connected with the first Fenton reactor (222), and the first coagulating sedimentation tank (223) is connected with the biochemical tank (11);
the high-concentration wastewater tank (221) is provided with a first collecting assembly (3) for collecting the diethyl aminoethyl hexanoate wastewater.
3. The plant growth hormone pro-drug wastewater treatment system of claim 2, wherein: the first collection assembly (3) comprises:
the first collecting tank (31) is arranged on the mounting frame (1) and is used for collecting the diethyl aminoethyl hexanoate wastewater;
the first delivery pump (32), first delivery pump (32) set up on first collection tank (31) and with first collection tank (31) in-connection, first delivery pump (32) are through first conveyer pipe (321) and high concentration waste water pond (221) intercommunication.
4. The plant growth hormone pro-drug wastewater treatment system of claim 2, wherein: the second processing assembly (23) comprises:
a high-salt wastewater tank (24), wherein the high-salt wastewater tank (24) is arranged on the mounting frame (1) and is used for collecting high-salt wastewater;
the defluorination sedimentation tank (25), wherein the defluorination sedimentation tank (25) is arranged on the mounting frame (1) and is connected with the high-salt wastewater tank (24) and is used for defluorinating wastewater;
the three-effect evaporator (26) is arranged on the mounting frame (1) and connected with the defluorination sedimentation tank (25) and used for removing salt in the wastewater, and the water outlet end of the three-effect evaporator (26) is connected with the biochemical tank (11);
and a second collecting component (4) for collecting the fluroxypyr is arranged on the high-salt wastewater tank (24).
5. The plant growth hormone pro-drug wastewater treatment system of claim 4, wherein: the second collection assembly (4) comprises:
the second collecting tank (41) is arranged on the mounting frame (1) and is used for collecting the fluroxypyr wastewater;
and a second delivery pump (42), wherein the second delivery pump (42) is arranged on the second collection tank (41) and is communicated with the second collection tank (41), and the second delivery pump (42) is communicated with the high-salt wastewater tank (24) through a second delivery pipe (421).
6. The plant growth hormone pro-drug wastewater treatment system of claim 1, wherein: be provided with monitoring mechanism (5) on clean water basin (12), monitoring mechanism (5) include:
the water quality monitor (51) is arranged on the clean water tank (12) and is used for monitoring the water quality in the clean water tank (12);
the water outlet pipe (52) is arranged on the clean water tank (12) and is connected with the clean water tank (12) in an internal connection mode and used for discharging the treated clean water, the water outlet pipe (52) is provided with a water outlet valve (521) which is controlled to be opened and closed, and the water outlet valve (521) is electrically connected with the water quality monitor (51);
and the reflux component (53) is arranged on the clean water tank (12) and is connected with the biochemical tank (11).
7. The plant growth hormone pro-drug wastewater treatment system of claim 6, wherein: the reflow assembly (53) includes:
the reflux pump (531), the said reflux pump (531) is set up on clean water tank (12) and communicated with clean water tank (12), the said reflux pump (531) is connected with on-line monitor electricity;
and a return pipe (532), wherein the return pipe (532) is arranged on the return pump (531) and is communicated with the biochemical tank (11).
8. The plant growth hormone pro-drug wastewater treatment system of claim 2, wherein: the biochemical tank (11), the clean water tank (12), the first coagulating sedimentation tank (223) and the defluorination sedimentation tank (25) are respectively provided with a sludge pump (13) for discharging sludge.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321712596.9U CN220166027U (en) | 2023-06-30 | 2023-06-30 | Plant growth hormone raw medicine wastewater treatment system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202321712596.9U CN220166027U (en) | 2023-06-30 | 2023-06-30 | Plant growth hormone raw medicine wastewater treatment system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN220166027U true CN220166027U (en) | 2023-12-12 |
Family
ID=89062943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202321712596.9U Active CN220166027U (en) | 2023-06-30 | 2023-06-30 | Plant growth hormone raw medicine wastewater treatment system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN220166027U (en) |
-
2023
- 2023-06-30 CN CN202321712596.9U patent/CN220166027U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110697986B (en) | Bacteria-algae coupling sewage treatment device based on energy recycling and use method thereof | |
| CN109437482A (en) | A kind of the efficient process system and its processing method of pharmaceutical industry production of raw medicine organic wastewater | |
| CN103288303A (en) | Livestock/poultry breeding wastewater resource utilization and regeneration recycling method | |
| CN204848572U (en) | Birds is raised and grows effluent treatment plant | |
| CN103304101A (en) | Resource utilization and regeneration circulation utilization device for livestock and poultry breeding wastewater | |
| CN207713595U (en) | Sewage treatment system for farm | |
| CN102583899A (en) | Sewage treatment technology and special system in bean product production process | |
| CN112694217A (en) | Power plant industrial wastewater treatment system and treatment method | |
| CN220166027U (en) | Plant growth hormone raw medicine wastewater treatment system | |
| CN112707605A (en) | Intelligent modularized wastewater treatment integrated system | |
| CN109942146B (en) | Integrated control constructed wetland tail water combined treatment device | |
| KR101035942B1 (en) | Method and system for treating domestic animal excretion | |
| CN208732868U (en) | A kind of integration apparatus of improved Forebay of Pumping Station water quality emergency processing | |
| CN213202768U (en) | Sludge biological treatment device | |
| CN210481124U (en) | Sewage treatment system is bred to beasts and birds | |
| CN105060616B (en) | Waste water purifying treatment system | |
| CN112591979A (en) | Sewage treatment process | |
| CN207811366U (en) | A kind of sewage disposal system | |
| CN105776764A (en) | Piggery wastewater treatment device and piggery wastewater treatment method | |
| CN111807640A (en) | High-efficiency industrial wastewater treatment method | |
| CN202643496U (en) | Sewage treatment-dedicated system in process of bean product production | |
| CN110183033A (en) | A kind of farm contains excrement, slag wastewater treatment fertilizer technique | |
| CN215365147U (en) | Large-scale pig farm sewage treatment and resource recycling system | |
| CN215049533U (en) | Integrated equipment for treating circuit board wastewater | |
| CN205295080U (en) | Integration food waste water treatment equipment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |